Abrdn Life Sciences Investors (HQL) — SC 13D/A Filings
All SC 13D/A filings from Abrdn Life Sciences Investors. Browse 5 SC 13D/A reports with AI-powered summaries and risk analysis.
SC 13D/A Filings (5)
-
Saba Capital Management Amends 13D Filing for abrdn Life Sciences
— Jun 3, 2024 Risk: medium
Saba Capital Management, L.P. has filed an amendment (No. 5) to its Schedule 13D/A regarding abrdn Life Sciences Investors. The filing, dated June 3, 2024, indi -
Saba Capital Management Amends abrdn Life Sciences Investors Filing
— Apr 29, 2024 Risk: medium
Saba Capital Management, L.P. has amended its Schedule 13D filing regarding abrdn Life Sciences Investors, as of April 29, 2024. The filing indicates changes in -
Saba Capital Management Amends 13D Filing for abrdn Life Sciences
— Apr 17, 2024 Risk: medium
Saba Capital Management, L.P. filed an amendment (No. 3) to its Schedule 13D on April 17, 2024, regarding its holdings in abrdn Life Sciences Investors. The fil -
Saba Capital Amends abrdn Life Sciences Investors Stake
— Feb 7, 2024
Saba Capital Management, L.P. filed an amended Schedule 13D/A on February 7, 2024, indicating a change in their beneficial ownership of abrdn Life Sciences Inve -
Saba Capital Amends abrdn Life Sciences Investors (HQL) 13D Filing
— Jan 12, 2024
Saba Capital Management, L.P. filed an amended Schedule 13D/A on January 12, 2024, updating its beneficial ownership in abrdn Life Sciences Investors. This amen
Popular Companies
AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX